InnoCan Pharma Corporation (CNSX: INNO)
Health Care · Pharmaceuticals · CA
CA$1.80
-18.18% today · -88.8% 1Y
InnoCan Pharma Corporation (CNSX: INNO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.99M and employs 11 people.
Over the last twelve months the share price has lost 88.8%, trading between 1.80 and 19.70.
Tweenvest scores InnoCan Pharma Corporation across four factors: quality 53/100, value 42/100, growth 100/100. Its strongest factor is growth.
INNO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.99M
- Revenue (TTM)
- $23.52M
- P/E
- —
- EPS
- -0.21
- Dividend yield
- —
- Beta (5Y)
- 0.30
- 52-week high
- CA$19.70
- 52-week low
- CA$1.80
- Avg volume (3M)
- —
- Shares outstanding
- 4.75M
- Employees
- 11
- Next earnings
- —
About InnoCan Pharma Corporation
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
- ISIN
- CA45783P5085
- Founded
- 2017
- Listed since
- Sep 25, 2019
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Phong Phu Pharmaceutical Joint Stock CompanyHNX: PPP | $6.16M | ₫— | — |
| Rekvina Laboratories LimitedBSE: 526075 | $6.15M | Rs53.55 | +7.40% |
| Blueberries Medical Corp.CNSX: BBM | $6.11M | CA$0.02 | -25.00% |
| NUTEX Investments Public Limited CompanyBUSE: NUTEX | $6.02M | Ft12.40 | +3.33% |
| Cardiac Biotech Solutions Inc.OTCPK: CBSC | $5.97M | $0.04 | +11.29% |
| Avant Brands Inc.TSX: AVNT | $5.93M | CA$0.55 | +7.84% |
| Sonoma Pharmaceuticals, Inc.NasdaqCM: SNOA | $5.89M | $1.23 | +6.03% |
| Gelteq LimitedNasdaqCM: GELS | $5.83M | $0.52 | -0.02% |
Figures last refreshed Oct 11, 2026.